HighTower Advisors
TMDX icon

HighTower Advisors’s Transmedics TMDX Stock Holding History

HighTower Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700
Closed -$55.6K – 4048
2024
Q3 		$55.6K Hold
700
– – ﹤0.01% 3399
2024
Q2 		$52.7K Hold
700
– – ﹤0.01% 3302
2024
Q1 		$10.6K Buy
+700
New +$57.7K ﹤0.01% 3399
2021
Q3 		– Sell
-1,000
Closed -$4K – 3437
2021
Q2 		$4K Buy
+1,000
New +$27.7K ﹤0.01% 3042

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

HighTower Advisors's TMDX Position: Q2 2026 in Review

HighTower Advisors reduced its Transmedics (TMDX) stake by 60% in Q2 2026, selling an estimated $631K and leaving 5,068 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #3112.

HighTower Advisors first reported a position in TMDX in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.63M in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • HighTower Advisors held 5,068 shares of Transmedics worth $337K as of Q2 2026.
  • HighTower Advisors sold 7,451 Transmedics shares in Q2 2026, an estimated $631K.
  • Transmedics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3112 holding.
  • HighTower Advisors first reported a position in Transmedics in Q1 2021 and has held it in 21 quarters since.
  • HighTower Advisors's Transmedics position peaked at $3.63M in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.